Table 1.
Experiment | n | Sex | Procedure 1 | Procedure 2 | NTX dose | Procedure 3 | Data |
---|---|---|---|---|---|---|---|
1 | 8 | Female | DID (26 Weeks) | SA training | 0–10 mg/kg; SC | PR testing | Figure 2; Table 2 |
6 | Male | DID (26 Weeks) | SA training | 0–10 mg/kg; SC | PR testing | Figure 2; Table 2 | |
2 | 8 | Female | CON & DID (16 weeks) | Hormone assays | 0 & 10 mg/kg; SC | - | Figures 1, 3, & 4 |
8 | Male | CON & DID (16 Weeks) | Hormone assays | 0 & 10 mg/kg; SC | - | Figures 1, 3, & 4 |
NTX, Naltrexone; DID, Modified drinking in the dark; CON, Control; SA, Self-administration; SC, Subcutaneous injection; PR, Progressive ratio.